{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:23:28Z","timestamp":1793413408724,"version":"4.5.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Antimicrobial resistance (AMR) in Neisseria gonorrhoeae is a global public health concern. Ceftriaxone is the last effective and recommended option for empirical gonorrhoea therapy worldwide, but several ceftriaxone-resistant cases linked to Asia have been reported internationally. During January 2022\u2013June 2023, the WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) investigated N. gonorrhoeae AMR and epidemiological factors in patients from 10 clinical sentinel sites in Cambodia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Urethral swabs from males with urethral discharge were cultured. ETEST determined the MIC of five antimicrobials, and EGASP MIC alert values and EUCAST breakpoints were used. EGASP demographic, behavioural and clinical variables were collected using a standardized questionnaire.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From 437 male patients, 306 had positive N. gonorrhoeae cultures, AMR testing and complete epidemiological data. Resistance to ceftriaxone, cefixime, azithromycin and ciprofloxacin was 15.4%, 43.1%, 14.4% and 97.1%, respectively. Nineteen (6.2%) isolates were resistant to all four antimicrobials and, accordingly, categorized as XDR N. gonorrhoeae. These XDR isolates were collected from 7 of the 10 sentinel sites. No EGASP MIC alert values for gentamicin were reported. The nationally recommended cefixime 400\u2005mg plus azithromycin 1\u2005g (65.4%) or ceftriaxone 1\u2005g plus azithromycin 1\u2005g (34.6%) was used for treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A high prevalence of ceftriaxone-resistant, MDR and XDR N. gonorrhoeae in several cities of Cambodia were found during 2022\u201323 in WHO EGASP. This necessitates expanded N. gonorrhoeae AMR surveillance, revision of the nationally recommended gonorrhoea treatment, mandatory test of cure, enhanced sexual contact notification, and ultimately novel antimicrobials for the treatment of gonorrhoea.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jacamr\/dlae053","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T14:15:54Z","timestamp":1712240154000},"source":"Crossref","is-referenced-by-count":54,"title":["High prevalence of ceftriaxone-resistant and XDR <i>Neisseria gonorrhoeae<\/i> in several cities of Cambodia, 2022\u201323: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)"],"prefix":"10.1093","volume":"6","author":[{"given":"V","family":"Ouk","sequence":"first","affiliation":[{"name":"National Center for HIV\/AIDS, Dermatology and Sexually Transmitted Diseases , Phnom Penh ,","place":["Cambodia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Say","family":"Heng","sequence":"additional","affiliation":[{"name":"National Center for HIV\/AIDS, Dermatology and Sexually Transmitted Diseases , Phnom Penh ,","place":["Cambodia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Virak","sequence":"additional","affiliation":[{"name":"Laboratory of the National Institute of Public Health , Phnom Penh ,","place":["Cambodia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Deng","sequence":"additional","affiliation":[{"name":"WHO, Office of Cambodia , Phnom Penh ,","place":["Cambodia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Lahra","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Sexually Transmitted Infections and Antimicrobial Resistance, New South Wales Health Pathology, Microbiology, The Prince of Wales Hospital , Randwick, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Frankson","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, CDC , Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kreisel","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, CDC , Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"McDonald","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, CDC , Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Escher","sequence":"additional","affiliation":[{"name":"AMR Division, WHO , Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Unemo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Medicine and Health, WHO Collaborating Centre for Gonorrhoea and other STIs, \u00d6rebro University , \u00d6rebro ,","place":["Sweden"]},{"name":"Institute for Global Health, University College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Wi","sequence":"additional","affiliation":[{"name":"Department of the Global HIV, Hepatitis and STI Programmes, WHO , Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1008-7413","authenticated-orcid":false,"given":"I","family":"Maatouk","sequence":"additional","affiliation":[{"name":"Department of the Global HIV, Hepatitis and STI Programmes, WHO , Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"EGASP Cambodia Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phnom","family":"Penh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Fensham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Kersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cavailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamuna","family":"Mundade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan J","family":"van Hal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratan L","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany R","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Whiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohiko","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nishijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"key":"2024102906063841700_dlae053-B1","author":"WHO"},{"key":"2024102906063841700_dlae053-B2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2024102906063841700_dlae053-B3","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","article-title":"WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017\u201318: a retrospective observational study","volume":"2","author":"Unemo","year":"2021","journal-title":"Lancet Microbe"},{"key":"2024102906063841700_dlae053-B4","author":"WHO"},{"key":"2024102906063841700_dlae053-B5","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1128\/AAC.00504-16","article-title":"New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan","volume":"60","author":"Nakayama","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2024102906063841700_dlae053-B6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/IM9.0000000000000113","article-title":"Global transmission of the penA allele 60.001\u2013containing high-level ceftriaxone-resistant gonococcal FC428 clone and antimicrobial therapy of associated cases: a review","volume":"5","author":"van der Veen","year":"2023","journal-title":"Infect Microb Dis"},{"key":"2024102906063841700_dlae053-B7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3201\/eid2404.171873","article-title":"Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain","volume":"24","author":"Lahra","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2024102906063841700_dlae053-B8","doi-asserted-by":"crossref","first-page":"1900118","DOI":"10.2807\/1560-7917.ES.2019.24.8.1900118","article-title":"Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018","volume":"24","author":"Jennison","year":"2019","journal-title":"Euro Surveill"},{"key":"2024102906063841700_dlae053-B9","doi-asserted-by":"crossref","first-page":"2200455","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200455","article-title":"Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022","volume":"27","author":"Pleininger","year":"2022","journal-title":"Euro Surveill"},{"key":"2024102906063841700_dlae053-B10","doi-asserted-by":"crossref","first-page":"1900528","DOI":"10.2807\/1560-7917.ES.2019.24.36.1900528","article-title":"Two cases of multidrug-resistant Neisseria gonorrhoeae related to travel in South-Eastern Asia, France, June 2019","volume":"24","author":"Poncin","year":"2019","journal-title":"Euro Surveill"},{"key":"2024102906063841700_dlae053-B11","doi-asserted-by":"crossref","first-page":"2300456","DOI":"10.2807\/1560-7917.ES.2023.28.37.2300456","article-title":"Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023","volume":"28","author":"Maubaret","year":"2023","journal-title":"Euro Surveill"},{"key":"2024102906063841700_dlae053-B12","author":"UNAIDS"},{"key":"2024102906063841700_dlae053-B13","author":"National Center for HIV\/AIDS Dermatology and STD"},{"key":"2024102906063841700_dlae053-B14","author":"National Center for HIV\/AIDS Dermatology and STD"},{"key":"2024102906063841700_dlae053-B15","author":"WHO"},{"key":"2024102906063841700_dlae053-B16","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action","volume":"14","author":"Wi","year":"2017","journal-title":"PLoS Med"},{"key":"2024102906063841700_dlae053-B17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1071\/SH19023","article-title":"World Health Organization global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts","volume":"16","author":"Unemo","year":"2019","journal-title":"Sex Health"},{"key":"2024102906063841700_dlae053-B18","first-page":"S47","article-title":"Strengthening global surveillance for antimicrobial drug-resistant Neisseria gonorrhoeae through the enhanced gonococcal antimicrobial surveillance program","volume":"23","author":"Weston","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2024102906063841700_dlae053-B19","author":"WHO"},{"key":"2024102906063841700_dlae053-B20","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/S1473-3099(23)00479-6","article-title":"The enhanced gonococcal surveillance programme, Cambodia","volume":"23","author":"Ouk","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2024102906063841700_dlae053-B21","author":"National Center for HIV\/AIDS Dermatology and STD"},{"key":"2024102906063841700_dlae053-B22","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1093\/jac\/dkw288","article-title":"The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization","volume":"71","author":"Unemo","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2024102906063841700_dlae053-B23","author":"EUCAST"},{"key":"2024102906063841700_dlae053-B24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/jac\/dkz054","article-title":"Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011\u201316","volume":"74","author":"Gianecini","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2024102906063841700_dlae053-B25","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/eri.09.63","article-title":"Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae","volume":"7","author":"Tapsall","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2024102906063841700_dlae053-B26","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/jac\/dkq289","article-title":"Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?","volume":"65","author":"Chisholm","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2024102906063841700_dlae053-B27","author":"WHO"},{"key":"2024102906063841700_dlae053-B28","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","article-title":"Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea","volume":"379","author":"Taylor","year":"2018","journal-title":"N Engl J Med"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/6\/2\/dlae053\/60183702\/dlae053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/6\/2\/dlae053\/60183702\/dlae053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T06:06:52Z","timestamp":1730182012000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlae053\/7640693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlae053","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,3,5]]},"article-number":"dlae053"}}